MSI-H CRC tumors also seem to have greater PD-L1 expression than their MSS counterparts, possibly suggesting that PD-1 checkpoint blockade may be particularly beneficial in the management of MSI-H CRC [10]. Here, CD274 is linked to colorectal carcinoma.